GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovid Therapeutics Inc (FRA:1OT) » Definitions » Net Interest Income (for Banks)

Ovid Therapeutics (FRA:1OT) Net Interest Income (for Banks)


View and export this data going back to 2017. Start your Free Trial

What is Ovid Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Ovid Therapeutics (FRA:1OT) Business Description

Industry
Traded in Other Exchanges
Address
441 Ninth Avenue, 14th Floor, New York, NY, USA, 10001
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class or best-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.